Published in Anesthesiology on July 01, 1992
Drugs and Brugada syndrome patients: review of the literature, recommendations, and an up-to-date website (www.brugadadrugs.org). Heart Rhythm (2009) 1.92
Genetic and biophysical basis for bupivacaine-induced ST segment elevation and VT/VF. Anesthesia unmasked Brugada syndrome. Heart Rhythm (2006) 1.56
Direct cardiac effects of intracoronary bupivacaine, levobupivacaine and ropivacaine in the sheep. Br J Pharmacol (2001) 0.84
Scavenging nanoparticles: an emerging treatment for local anesthetic toxicity. Reg Anesth Pain Med (2005) 0.79
Brugada syndrome and pregnancy: highlights on antenatal and prenatal management. Case Rep Obstet Gynecol (2014) 0.76
Safety of paediatric neuraxial blocks: Revisited. Indian J Anaesth (2013) 0.75
Supraventricular tachycardia after an intercostal nerve block with bupivacaine treated with 10% intralipid. J Anaesthesiol Clin Pharmacol (2011) 0.75
Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol (1992) 12.18
Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation (1995) 8.62
A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation (1991) 7.45
Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature (1998) 7.26
Identification of a genetic locus for familial atrial fibrillation. N Engl J Med (1997) 4.66
Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res (1999) 4.57
Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation (2000) 3.99
Proposed diagnostic criteria for the Brugada syndrome. Eur Heart J (2002) 3.01
Brief report: the hemodynamic mechanism of pounding in the neck in atrioventricular nodal reentrant tachycardia. N Engl J Med (1992) 2.96
High-density mapping of electrically induced atrial fibrillation in humans. Circulation (1994) 2.94
Idiopathic short QT interval: a new clinical syndrome? Cardiology (2000) 2.85
Verapamil reduces tachycardia-induced electrical remodeling of the atria. Circulation (1997) 2.44
Redistribution of myocardial fiber strain and blood flow by asynchronous activation. Am J Physiol (1990) 2.37
Configuration of unipolar atrial electrograms during electrically induced atrial fibrillation in humans. Circulation (1997) 2.29
Long-lasting sport practice and lone atrial fibrillation. Eur Heart J (2002) 2.26
Sinus node automaticity during atrial fibrillation in isolated rabbit hearts. Circulation (1992) 2.21
Influences of anisotropic tissue structure on reentrant circuits in the epicardial border zone of subacute canine infarcts. Circ Res (1988) 2.21
Sudden death in patients and relatives with the syndrome of right bundle branch block, ST segment elevation in the precordial leads V(1)to V(3)and sudden death. Eur Heart J (2000) 2.18
Length of excitation wave and susceptibility to reentrant atrial arrhythmias in normal conscious dogs. Circ Res (1988) 2.13
Altered pattern of connexin40 distribution in persistent atrial fibrillation in the goat. J Cardiovasc Electrophysiol (1998) 1.85
The differential diagnosis of a regular tachycardia with a wide QRS complex on the 12-lead ECG: ventricular tachycardia, supraventricular tachycardia with aberrant intraventricular conduction, and supraventricular tachycardia with anterograde conduction over an accessory pathway. Pacing Clin Electrophysiol (1994) 1.84
Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat. Cardiovasc Res (2000) 1.81
Longitudinal dissociation of atrioventricular accessory pathways. J Am Coll Cardiol (1991) 1.65
Prognostic value of electrophysiologic investigations in Brugada syndrome. J Cardiovasc Electrophysiol (2001) 1.58
Nonlinear analysis of epicardial atrial electrograms of electrically induced atrial fibrillation in man. J Cardiovasc Electrophysiol (1995) 1.56
Brugada syndrome: a decade of progress. Circ Res (2002) 1.54
Usefulness of transoesophageal echocardiography before circumferential pulmonary vein ablation in patients with atrial fibrillation: is it really mandatory? Europace (2010) 1.49
"Early" class III drugs for the treatment of atrial fibrillation: efficacy and atrial selectivity of AVE0118 in remodeled atria of the goat. Circulation (2004) 1.48
Circus movement in rabbit atrial muscle as a mechanism of trachycardia. Circ Res (1973) 1.42
Repetitive electrical remodeling by paroxysms of atrial fibrillation in the goat: no cumulative effect on inducibility or stability of atrial fibrillation. J Cardiovasc Electrophysiol (1999) 1.42
Profibrillatory effects of verapamil but not of digoxin in the goat model of atrial fibrillation. J Cardiovasc Electrophysiol (2000) 1.40
Hypertrophic cardiomyopathy: role of the implantable cardioverter-defibrillator. J Am Coll Cardiol (1998) 1.38
Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation (1997) 1.37
The time sequence of electrical and mechanical activation during spontaneous beating and ectopic stimulation. Eur Heart J (1992) 1.37
The wavelength of the cardiac impulse and reentrant arrhythmias in isolated rabbit atrium. The role of heart rate, autonomic transmitters, temperature, and potassium. Circ Res (1986) 1.34
Regional entrainment of atrial fibrillation studied by high-resolution mapping in open-chest dogs. Circulation (1993) 1.31
Investigation of palpitations. Lancet (1993) 1.28
Reentrant excitation around a fixed obstacle in uniform anisotropic ventricular myocardium. Circulation (1991) 1.27
Cellular mechanisms of depressed atrial contractility in patients with chronic atrial fibrillation. Circulation (2001) 1.27
Electrical storm in Brugada syndrome successfully treated using isoprenaline. Europace (2004) 1.24
Electrophysiologic mapping to determine the mechanism of experimental ventricular tachycardia initiated by premature impulses. Experimental approach and initial results demonstrating reentrant excitation. Am J Cardiol (1982) 1.24
In vitro study on mechanisms of bupivacaine-induced depression of myocardial contractility. Anesth Analg (1989) 1.23
Early recurrences of atrial fibrillation after electrical cardioversion: a result of fibrillation-induced electrical remodeling of the atria? J Am Coll Cardiol (1998) 1.22
Enhanced susceptibility for acquired torsade de pointes arrhythmias in the dog with chronic, complete AV block is related to cardiac hypertrophy and electrical remodeling. Circulation (1998) 1.21
The Brugada syndrome. Curr Cardiol Rep (2000) 1.20
Differential effects of heptanol, potassium, and tetrodotoxin on reentrant ventricular tachycardia around a fixed obstacle in anisotropic myocardium. Circulation (1991) 1.20
Arrhythmia induction by antiarrhythmic drugs. Pacing Clin Electrophysiol (2000) 1.19
Quantification of spatial inhomogeneity in conduction and initiation of reentrant atrial arrhythmias. Am J Physiol (1990) 1.16
Anisotropic conduction and reentry in perfused epicardium of rabbit left ventricle. Am J Physiol (1992) 1.07
Regional control of atrial fibrillation by rapid pacing in conscious dogs. Circulation (1991) 1.06
Intra-atrial reentry as a mechanism for atrial flutter induced by acetylcholine and rapid pacing in the dog. Circulation (1984) 1.04
Minimum Information about a Cardiac Electrophysiology Experiment (MICEE): standardised reporting for model reproducibility, interoperability, and data sharing. Prog Biophys Mol Biol (2011) 1.03
Ventricular fibrillation and sudden death after radiofrequency catheter ablation of the atrioventricular junction. Pacing Clin Electrophysiol (1997) 1.03
Cardioversion of persistent atrial fibrillation by a combination of atrial specific and non-specific class III drugs in the goat. Cardiovasc Res (2007) 1.02
Atrioventricular nodal reentrant tachycardia: a review. Can J Cardiol (1994) 1.01
Structural changes of atrial myocardium during chronic atrial fibrillation. Cardiovasc Pathol (2000) 0.97
[Sudden cardiac death out of the hospital and early defibrillation]. Rev Esp Cardiol (2000) 0.97
A fast and reliable algorithm to localize accessory pathways based on the polarity of the QRS complex on the surface ECG during sinus rhythm. Pacing Clin Electrophysiol (1995) 0.97
Hemodynamic deterioration following radiofrequency ablation of the atrioventricular conduction system. Pacing Clin Electrophysiol (1997) 0.96
Dispersion-based reentry: mechanism of initiation of ventricular tachycardia in isolated rabbit hearts. Am J Physiol (1999) 0.94
Atrial fibrillation-induced electrical remodeling in humans: what is the next step? Cardiovasc Res (1999) 0.94
Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol. Circulation (2000) 0.94
The influence of the atrial myocardium on impulse formation in the rabbit sinus node. Pflugers Arch (1987) 0.93
Epicardial and subselective transcoronary chemical ablation of incessant ventricular tachycardia. Cathet Cardiovasc Diagn (1993) 0.93
Anisotropic reentry in a perfused 2-dimensional layer of rabbit ventricular myocardium. Circulation (2000) 0.92
Long-term follow-up in patients with the permanent form of junctional reciprocating tachycardia treated with radiofrequency ablation. Pacing Clin Electrophysiol (1998) 0.92
The electrocardiographic, clinical, and electrophysiologic spectrum of idiopathic monomorphic ventricular tachycardia. Am Heart J (1992) 0.90
Atrial high energy phosphate content and mitochondrial enzyme activity during chronic atrial fibrillation. Cardiovasc Res (2000) 0.90
Cardiomyocyte remodelling during myocardial hibernation and atrial fibrillation: prelude to apoptosis. Cardiovasc Res (1999) 0.90
Use of the prophylactic implantable cardioverter defibrillator for patients with normal hearts. Am J Cardiol (1999) 0.89
The ajmaline challenge in Brugada syndrome: a useful tool or misleading information? Eur Heart J (2003) 0.88
Atrial fibrillation in the goat induces changes in monophasic action potential and mRNA expression of ion channels involved in repolarization. J Cardiovasc Electrophysiol (2000) 0.88
Mode of action of a new class IC drug (ORG 7797) against atrial fibrillation in conscious dogs. J Cardiovasc Pharmacol (1991) 0.88
Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation. J Mol Cell Cardiol (2000) 0.88
Radiofrequency ablation of symptomatic but benign ventricular arrhythmias. Pacing Clin Electrophysiol (1992) 0.87
Sudden death in high-risk family members: Brugada syndrome. Am J Cardiol (2000) 0.86
Impulse propagation from the SA-node to the ventricles. Experientia (1987) 0.85
Sinus node response to premature atrial stimulation in the rabbit studied with multiple microelectrode impalements. Circ Res (1978) 0.85
RP 58866 and its active enantiomer RP 62719 (terikalant): blockers of the inward rectifier K+ current acting as pure class III antiarrhythmic agents. J Cardiovasc Pharmacol (1992) 0.84
Vulnerability of rabbit atrium to reentry by hypoxia. Role of inhomogeneity in conduction and wavelength. Am J Physiol (1992) 0.84
Electrophysiological effects of acute dilatation in the isolated rabbit heart: cycle length-dependent effects on ventricular refractoriness and conduction velocity. Circulation (1997) 0.84
Digoxin delays recovery from tachycardia-induced electrical remodeling of the atria. Circulation (1999) 0.84
Entrainment of reentrant ventricular tachycardia in anisotropic rings of rabbit myocardium. Mechanisms of termination, changes in morphology, and acceleration. Circulation (1993) 0.84
Evidence for the presence of electrotonic depression of pacemakers in the rabbit atrioventricular node. The effects of uncoupling from the surrounding myocardium. Basic Res Cardiol (1988) 0.83
Direct demonstration of sinus node reentry in the rabbit heart. Circ Res (1979) 0.82
The Brugada Syndrome. Arch Mal Coeur Vaiss (2005) 0.82
[Mechanisms of the cardiac toxicity of bupivacaine]. Ann Fr Anesth Reanim (1988) 0.81
'Localized' right ventricular morphological abnormalities in patients with the Brugada syndrome: what is their significance? Eur Heart J (2001) 0.81
[Prospective and comparative study of pacemaker implants carried out at the electrophysiology laboratory and the operating room]. Rev Esp Cardiol (2000) 0.80
Ventricular beats induce variations in cycle length of rapid (type II) atrial flutter in humans. Evidence of leading circle reentry. Circulation (1994) 0.80
Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol. J Cardiovasc Electrophysiol (1999) 0.80
Electrical remodeling and atrial dilation during atrial tachycardia are influenced by ventricular rate: role of developing tachycardiomyopathy. J Cardiovasc Electrophysiol (2001) 0.80
Low recurrence of syncope in patients with inducible sustained ventricular tachyarrhythmias treated with an implantable cardioverter-defibrillator. Eur Heart J (2002) 0.80
Mapping of reset of anatomic and functional reentry in anisotropic rabbit ventricular myocardium. Circulation (1994) 0.79
Effects of heptanol, class Ic, and class III drugs on reentrant ventricular tachycardia. Importance of the excitable gap for the inducibility of double-wave reentry. Circulation (1994) 0.79
Genetic testing of candidate genes in arrhythmogenic right ventricular cardiomyopathy/dysplasia. Eur J Med Genet (2012) 0.79
Arrhythmia recurrence in patients with a healed myocardial infarction who received an implantable defibrillator: analysis according to the clinical presentation. J Am Coll Cardiol (1999) 0.79
Quantification of left ventricular asynchrony throughout the whole cardiac cycle with a computed algorithm: application for optimizing resynchronization therapy. J Cardiovasc Electrophysiol (2009) 0.79